Stocks and Investing
Stocks and Investing
Ami Fadia Initiated (TEVA) at Sell and Held Target at $15 on, Jan 2nd, 2018
Ami Fadia of Leerink Swann, Initiated "Teva Pharmaceutical Industries Limited" (TEVA) at Sell and Held Target at $15 on, Jan 2nd, 2018.
Ami has made no other calls on TEVA in the last 4 months.
There are 9 other peers that have a rating on TEVA. Out of the 9 peers that are also analyzing TEVA, 6 agree with Ami's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- David Risinger of "Morgan Stanley" Upgraded from Sell to Hold on, Friday, December 15th, 2017
- Vamil Divan of "Credit Suisse" Upgraded from Sell to Hold on, Friday, December 15th, 2017
- Rohit Vanjani of "Guggenheim" Initiated at Hold and Held Target at $16 on, Tuesday, December 12th, 2017
- Liav Abraham of "Citigroup" Maintained at Hold with Decreased Target to $13 on, Monday, November 13th, 2017
- Gregg Gilbert of "Deutsche Bank" Downgraded from Strong Buy to Hold on, Friday, November 3rd, 2017
- Douglas Tsao of "Barclays" Maintained at Hold with Decreased Target to $19 on, Friday, October 20th, 2017
These are the ratings of the 3 analyists that currently disagree with Ami
- Jami Rubin of "Goldman Sachs" Upgraded from Hold to Strong Buy on, Friday, December 15th, 2017
- Chris Schott of "JP Morgan" Downgraded from Hold to Sell on, Monday, November 13th, 2017
- Tim Chiang of "BTIG" Upgraded from Hold to Strong Buy and Held Target at $24 on, Monday, September 11th, 2017